Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-01-29 @ 4:54 PM
Study NCT ID:
NCT00716859
Status:
COMPLETED
Last Update Posted:
2021-02-03
First Post:
2008-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Glaucoma | View |
Keywords: